Page last updated: 2024-11-07

penicillamine and Hyperlipoproteinemia Type III

penicillamine has been researched along with Hyperlipoproteinemia Type III in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonet Serra, B1
Henry Knopp, R1

Reviews

1 review available for penicillamine and Hyperlipoproteinemia Type III

ArticleYear
[Type-III hyperlipoproteinemia in a girl with Wilson's disease].
    Anales espanoles de pediatria, 1999, Volume: 50, Issue:1

    Topics: Biopsy; Child; Female; Hepatolenticular Degeneration; Humans; Hyperlipoproteinemia Type III; Lipopro

1999